Merck & Co., Inc.
corporate_fare Company Profile
Merck & Co., Inc. (NYSE:MRK) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 66 items for MRK at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Merck Finalizes $6 Billion Debt Offering to Repay Terns Acquisition Loan
- Merck Prices $6.0 Billion Multi-Tranche Debt Offering to Repay Terns Acquisition Financing
- Merck's Sacituzumab Tirumotecan Trial Hits Key Survival Endpoints in Endometrial Cancer
- Merck's Keytruda-Moderna Vaccine Trial Advances, Gardasil Litigation Sees Mixed Outcomes
- Merck Reports Q1 GAAP Net Loss Driven by $9.0B Cidara Acquisition Charge; Updates on Key Products & Pipeline
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$65.01B
Net Income
$18.25B
Diluted EPS
$7.28
Op. Cash Flow
$16.47B
Free Cash Flow
$12.36B
Gross Profit
$48.63B
Cash & Equivalents
$14.56B
Total Debt
$49.05B
Debt / Equity
0.93×
Net Margin
28.1%
Shares Outstanding
2.5B sh
Source: 10-K · filed 2026-02-24 · accession 0000310158-26-000063
show_chartPrice Chart
Loading chart...
feed MRK - Filings & News (Page 3)
MRK
May 20, 2026, 4:23 PM EDT
Price at Filing:
$113.25
Real-time Price:
$141.73
Change:
+$28.48 (+25%)
Market Cap:
$349.672B
MRK
May 18, 2026, 6:41 PM EDT
Price at Filing:
$112.18
Real-time Price:
$141.73
Change:
+$29.55 (+26%)
Market Cap:
$349.672B
MRK
May 18, 2026, 6:48 AM EDT
Price at Filing:
$111.37
Real-time Price:
$141.73
Change:
+$30.36 (+27%)
Market Cap:
$349.672B
MRK
May 08, 2026, 4:06 PM EDT
Price at Filing:
$111.38
Real-time Price:
$141.73
Change:
+$30.35 (+27%)
Market Cap:
$349.672B
MRK
May 04, 2026, 4:10 PM EDT
Price at Filing:
$113.11
Real-time Price:
$141.73
Change:
+$28.62 (+25%)
Market Cap:
$349.672B
MRK
Apr 30, 2026, 6:53 AM EDT
Price at Filing:
$113.00
Real-time Price:
$141.73
Change:
+$28.73 (+25%)
Market Cap:
$349.672B
MRK
Apr 30, 2026, 6:30 AM EDT
Price at Filing:
$115.00
Real-time Price:
$141.73
Change:
+$26.73 (+23%)
Market Cap:
$349.672B
MRK
Apr 30, 2026, 6:30 AM EDT
Price at Filing:
$112.94
Real-time Price:
$141.73
Change:
+$28.79 (+25%)
Market Cap:
$349.672B
MRK
Apr 24, 2026, 6:45 AM EDT
Price at Filing:
$113.99
Real-time Price:
$141.73
Change:
+$27.74 (+24%)
Market Cap:
$349.672B
MRK
Apr 21, 2026, 11:50 AM EDT
Price at Filing:
$112.55
Real-time Price:
$141.73
Change:
+$29.18 (+26%)
Market Cap:
$349.672B
MRK
Apr 21, 2026, 6:51 AM EDT
Price at Filing:
$116.99
Real-time Price:
$141.73
Change:
+$24.74 (+21%)
Market Cap:
$349.672B
MRK
Apr 20, 2026, 7:29 AM EDT
Price at Filing:
$118.52
Real-time Price:
$141.73
Change:
+$23.21 (+20%)
Market Cap:
$349.672B
MRK
Apr 13, 2026, 4:06 PM EDT
Price at Filing:
$119.66
Real-time Price:
$141.73
Change:
+$22.07 (+18%)
Market Cap:
$349.672B
MRK
Apr 08, 2026, 4:25 PM EDT
Price at Filing:
$123.49
Real-time Price:
$141.73
Change:
+$18.24 (+15%)
Market Cap:
$349.672B
MRK
Mar 30, 2026, 4:04 PM EDT
Price at Filing:
$118.10
Real-time Price:
$141.73
Change:
+$23.63 (+20%)
Market Cap:
$349.672B
MRK
Mar 30, 2026, 11:48 AM EDT
Merck's Oral PCSK9 Inhibitor Enlicitide Decanoate Slashes LDL-C by 64.6%, Earns FDA Priority Voucher
Price at Filing:
$118.06
Real-time Price:
$141.73
Change:
+$23.67 (+20%)
Market Cap:
$349.672B
MRK
Mar 29, 2026, 11:49 AM EDT
Price at Filing:
$119.27
Real-time Price:
$141.73
Change:
+$22.46 (+19%)
Market Cap:
$349.672B
MRK
Mar 25, 2026, 6:45 AM EDT
Price at Filing:
$116.68
Real-time Price:
$141.73
Change:
+$25.05 (+21%)
Market Cap:
$349.672B
MRK
Mar 24, 2026, 9:03 PM EDT
Price at Filing:
$116.68
Real-time Price:
$141.73
Change:
+$25.05 (+21%)
Market Cap:
$349.672B
MRK
Mar 05, 2026, 3:04 PM EST
Price at Filing:
$115.78
Real-time Price:
$141.73
Change:
+$25.95 (+22%)
Market Cap:
$349.672B